Oral Antiplatelet Efficacy of the Platelet GPIIb/IIIa Antagonist, DMP754 in Non-Human Primates - Receptor binding affinity & specificity

By Mousa S.A.   Bozarth J.   Youssef A.   Levine B.  

Thrombosis Research, Vol. 89, Iss. 5, 1998-03 ,pp. : 217-225

Elsevier

Access to resources Recommend Favorite

The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIb/IIIa antagonist

By Aoki T.   Cox D.   Senzaki K.   Seki J.   Tanaka A.   Takasugi H.   Motoyama Y.  

Thrombosis Research, Vol. 81, Iss. 4, 1996-02 ,pp. : 439-450

Elsevier

Access to resources Recommend Favorite

Antiplatelet and Antithrombotic Effects of Orbofiban, a New Orally Active GPIIb/IIIa Antagonist, in Guinea Pigs

By Ogawa T.   Sugidachi A.   Naganuma H.   Asai F.  

Thrombosis Research, Vol. 97, Iss. 5, 2000-03 ,pp. : 307-315

Elsevier

Access to resources Recommend Favorite

Antithrombotic Effect of SM-20302, a Nonpeptide GPIIb/IIIa Antagonist, in a Photochemically Induced Thrombosis Model in Guinea Pigs - IMPACT-II

By Horisawa S.   Kaneko M.   Ikeda Y.   Ueki Y.   Sakurama T.  

Thrombosis Research, Vol. 94, Iss. 4, 1999-05 ,pp. : 227-234

Elsevier

Access to resources Recommend Favorite

Comparison of the Antithrombotic Effects of FK633, GPIIb/IIIa Antagonist, and Aspirin in a Guinea Pig Thrombosis Model - Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients

By Aoki T.   Cox D.   Senzaki K.   Seki J.   Tanaka A.   Takasugi H.   Motoyama Y.  

Thrombosis Research, Vol. 89, Iss. 3, 1998-02 ,pp. : 129-136

Elsevier

Access to resources Recommend Favorite